Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Dropped 43.7% in First Half of 2022

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 63.8 million yuan in the first half of 2022, down 43.7% year-on-year.

Meanwhile, the company posted 768.8 million yuan in revenue, up 0.1% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 30.3%.